about
Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissueCysteine S-Nitrosylation Protects Protein-tyrosine Phosphatase 1B against Oxidation-induced Permanent InactivationHuman sperm binding is mediated by the sialyl-Lewis(x) oligosaccharide on the zona pellucidaMycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effectsIn vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptidesPhosphorylation of the zebrafish M6Ab at serine 263 contributes to filopodium formation in PC12 cells and neurite outgrowth in zebrafish embryosDistribution of the Galβ1-4Gal epitope among birds: species-specific loss of the glycan structure in chicken and its relativesAGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycanAn invertebrate Warburg effect: a shrimp virus achieves successful replication by altering the host metabolome via the PI3K-Akt-mTOR pathwayIn vivo regulation of steroid hormones by the Chst10 sulfotransferase in mouseQuantitative apical membrane proteomics reveals vasopressin-induced actin dynamics in collecting duct cellsNovel LC-MS² product dependent parallel data acquisition function and data analysis workflow for sequencing and identification of intact glycopeptides.Identification of blood group A/A-Leb/y and B/B-Leb/y active glycotopes co-expressed on the O-glycans isolated from two distinct human ovarian cyst fluids.Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods.Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N-glycan.Distinctive characteristics of MALDI-Q/TOF and TOF/TOF tandem mass spectrometry for sequencing of permethylated complex type N-glycans.Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study.Concerted experimental approach for sequential mapping of peptides and phosphopeptides using C18-functionalized magnetic nanoparticles.Characterization of a distinct arabinofuranosyltransferase in Mycobacterium smegmatis.Glycomic mapping of pseudomucinous human ovarian cyst glycoproteins: identification of Lewis and sialyl Lewis glycotopes.The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactanIdentification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses.Precise mapping of increased sialylation pattern and the expression of acute phase proteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics.Developmental regulation of oligosialylation in zebrafish.Glycomics and proteomics analyses of mouse uterine luminal fluid revealed a predominance of Lewis Y and X epitopes on specific protein carriers.Determination of N-glycosylation site and glycan structures of pectin methylesterase in jelly fig (Ficus awkeotsang) Achenes.Phosphoproteomics of Klebsiella pneumoniae NTUH-K2044 reveals a tight link between tyrosine phosphorylation and virulenceAttenuation of fibroblast growth factor signaling by poly-N-acetyllactosamine type glycansTerminal disialylated multiantennary complex-type N-glycans carried on acutobin define the glycosylation characteristics of the Deinagkistrodon acutus venom.Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samplesSwitching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.Immunogenic glycoconjugates implicated in parasitic nematode diseases.Correlation between the glycan variations and defibrinogenating activities of acutobin and its recombinant glycoforms.Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.A new insect cell glycoengineering approach provides baculovirus-inducible glycogene expression and increases human-type glycosylation efficiency.MS-based glycomic strategies for probing the structural details of polylactosaminoglycan chain on N-glycans and glycoproteomic identification of its protein carriers.Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages.Rapid glycopeptide enrichment and N-glycosylation site mapping strategies based on amine-functionalized magnetic nanoparticles.GEF-H1 controls focal adhesion signaling that regulates mesenchymal stem cell lineage commitment.
P50
Q24622257-30D8776F-19F7-4030-B127-6525E4FA187FQ27652444-2B8865BB-1E41-479D-9976-9F429FDC049AQ28245912-F988B734-AB93-452F-B65D-602A7471E033Q28260573-B840DAD5-A6C6-40B2-82B9-1C705FDE08B8Q28273553-87CF867E-9EE2-4A05-B218-9FD32C3291A1Q28477554-61556897-822E-42A6-94C2-3BF7393C770CQ28488232-65799EFB-2B6B-49B2-8CCF-E6D6525FAFC3Q28511766-40974C25-0286-4923-BC6C-BA6D737EBBA8Q28539677-F36AD1D8-7313-4194-8F9B-762329D8152EQ30422202-69E68272-53B7-499F-9CFF-0F900D1F3C62Q30552150-9A2FB450-FAF1-4943-8C02-A059C8ACC341Q30814409-29DD8F0F-2E5B-4FB4-BC74-ECAC3215E6C0Q30870762-26E00971-FEFA-42CE-B0ED-6B0656F6C46DQ31107717-AF1CBE64-2899-44B6-8882-1D2E777A5200Q31139135-C531C8A8-39A4-480C-A60D-175E644F760FQ33253362-0A142D85-C8AA-4A77-A942-7D2D958B9023Q33269243-3D82504D-E7AF-46F5-921D-E9D413194C61Q33277617-8881AB00-58E9-4E1A-A183-FE72D1DA223AQ33290811-03AD8D03-0E99-4214-BA28-22CB63DC880BQ33299546-4CD12A44-1125-4186-97F4-63F0E91866E7Q33321365-19AA7CC6-6A44-4578-8049-1B476468E468Q33328376-2C867434-F008-4E9E-94A1-AD8936C2CA57Q33343248-39AA033D-43B6-45B6-801D-DD50E2799CD6Q33360313-173CB345-7FF2-4785-BACD-1E075F61CC92Q33378420-7F075BC0-B9CE-4248-B294-CAEE109C3A18Q33481139-C846C160-1B32-421C-86A6-5F7A410AC602Q33628897-BAE8509B-8E01-4F3B-86FA-004D7E40856CQ33643328-FEB2F7C5-5674-4755-A831-6848EA6641A4Q33755675-AB2F8C91-3C64-48CA-B119-87CC01AB18A0Q33764300-62AFF59B-6C33-4FB1-A8BA-FDB4A714790AQ33768401-C40B9A06-5CA8-45EF-8F5E-D1CCFBA1F0EEQ33778470-12FE0208-BB12-4990-9950-4E921728AACBQ33778892-B6FFDB2E-222B-432E-8D84-F7E08B6E64B9Q33812834-7E4F4A26-612E-41D5-AD06-A70C922D80BAQ33888457-5B89A10C-CAC8-4FFA-8714-48FE93DC578FQ33893766-BA146C76-DBE1-4F70-BE73-60E26FCB9B20Q33927737-C1A6C309-2DD8-4B30-833E-8354B72A938AQ34034577-ADFFF1E5-08BB-4BB1-A99F-D22B0E4115B8Q34144260-2EF471A6-A348-46D5-BB29-7C41B4A17AA8Q34264512-FAC70EF9-5FC9-4253-9377-9E907A8010EF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kay-Hooi Khoo
@ast
Kay-Hooi Khoo
@en
Kay-Hooi Khoo
@es
Kay-Hooi Khoo
@nl
type
label
Kay-Hooi Khoo
@ast
Kay-Hooi Khoo
@en
Kay-Hooi Khoo
@es
Kay-Hooi Khoo
@nl
prefLabel
Kay-Hooi Khoo
@ast
Kay-Hooi Khoo
@en
Kay-Hooi Khoo
@es
Kay-Hooi Khoo
@nl
P108
P106
P108
P21
P31
P496
0000-0003-2906-406X